Avenue Therapeutics

$3.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (+1.22%) Today
-$0.03 (-0.90%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell ATXI and other stocks, options, and ETFs commission-free!

About ATXI

Avenue Therapeutics, Inc. engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, which is intended for the treatment of moderate to moderately severe post-operative pain. The company was founded on February 9, 2015 and is headquartered in New York, NY. The listed name for ATXI is Avenue Therapeutics, Inc. Common Stock.

CEO
Lucy Lu
Employees
4
Headquarters
New York, New York
Founded
2015
Market Cap
55.77M
Price-Earnings Ratio
Dividend Yield
Average Volume
131.97K
High Today
$3.39
Low Today
$3.24
Open Price
$3.29
Volume
91.05K
52 Week High
$12.34
52 Week Low
$2.85

Collections

ATXI Earnings

-$0.82
-$0.55
-$0.27
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 29, After Hours

You May Also Like